Literature DB >> 24762033

Assessment of treatment-seeking behavior and healthcare utilization in an international cohort of subjects with overactive bladder.

Miguel Jimenez-Cidre1, Pierre Costa, Daisy Ng-Mak, Arun Sahai, Arnold Degboe, Christopher Patrick Smith, Kathleen Tsai, Sender Herschorn.   

Abstract

UNLABELLED: Abstract Objective: To assess the association between incontinence severity, treatment-seeking behavior, and healthcare resource utilization (HRU) among participants with overactive bladder (OAB) in eight countries. RESEARCH DESIGN AND METHODS: A cross-sectional online survey of subjects ≥18 years old in Australia, Europe, and North America, who had a past OAB diagnosis and/or experienced ≥1 urinary incontinence (UI) episode in the preceding 12 months, were eligible to participate. Subjects contacted for the survey were primarily from a voluntary medication monitoring registry, MediGuard. Predominantly stress incontinence subjects were excluded. Incontinence severity was assessed by the number of UI episodes over 3 days and grouped as 0 ('dry'), 1-2, 3-4, and ≥5 UI episodes/day. Subject demographics, employment status, comorbidities, treatment-seeking behavior (past OAB diagnosis; spoken to healthcare provider [HCP]), and HRU (diagnostic tests; HCP visits in 6 months before screening) were analyzed by incontinence severity.
RESULTS: Overall, 1341 subjects with OAB (mean age 54.5 years; 70.7% female) were surveyed; 20.2%, 47.7%, 18.8%, and 13.3% of subjects reported 0, 1-2, 3-4, and ≥5 UI episodes/day, respectively. Employment status and comorbidities were significantly (p < 0.05) associated with incontinence severity. The two measures of treatment-seeking behavior were significantly (p < 0.05) associated with incontinence severity groups; the proportion of subjects with a past diagnosis of OAB were 35.8%, 44.8%, 52.4%, and 64.0% in the 0, 1-2, 3-4, and ≥5 UI episodes/day groups, respectively; and 59.0%, 63.6%, 65.9%, and 78.1% of subjects in the respective UI severity groups talked to a HCP about their OAB symptoms. Multivariate linear regression analyses showed a positive and consistent association between incontinence severity and HRU; subjects reported a mean of 2.7, 4.1, 4.4, and 7.7 diagnostic tests overall (p < 0.001), and a mean of 1.4, 2.2, 2.7, and 4.0 HCP visits in the 0, 1-2, 3-4, and ≥5 UI episodes/day groups, respectively (p < 0.001). A potential limitation of the study is the cross-sectional survey methodology which limits the ability to draw causal inferences from the results. Additionally, since this is a web-based survey it is possible respondents who have access to/are familiar with technology were more likely to be enrolled.
CONCLUSIONS: Incontinence severity was positively associated with both treatment-seeking behavior and HRU among subjects with OAB.

Entities:  

Keywords:  Burden of incontinence; Healthcare resource utilization; Incontinence severity; Overactive bladder; Treatment-seeking behavior; Urinary incontinence; Urinary symptoms

Mesh:

Year:  2014        PMID: 24762033     DOI: 10.1185/03007995.2014.918028

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  6 in total

1.  Cost-effectiveness of a behavioral intervention for persistent urinary incontinence in prostate cancer patients.

Authors:  Amy Y Zhang; Alex Z Fu
Journal:  Psychooncology       Date:  2015-05-12       Impact factor: 3.894

Review 2.  Advancing a Comprehensive Approach to the Study of Lower Urinary Tract Symptoms.

Authors:  Tamara G Bavendam; Jenna M Norton; Ziya Kirkali; Chris Mullins; John W Kusek; Robert A Star; Griffin P Rodgers
Journal:  J Urol       Date:  2016-06-21       Impact factor: 7.450

3.  Impact of overactive bladder on quality of life and resource use: results from Korean Burden of Incontinence Study (KOBIS).

Authors:  Kyu Sung Lee; Myung Soo Choo; Ju Tae Seo; Seung June Oh; Hyeong Gon Kim; Kwong Ng; Kyung Jin Lee; Jonathan T Tan; Joon Chul Kim
Journal:  Health Qual Life Outcomes       Date:  2015-06-26       Impact factor: 3.186

4.  Factors Associated with Improvements in Patient-Reported Outcomes During Mirabegron or Antimuscarinic Treatment of Overactive Bladder Syndrome: A Registry Study (PERSPECTIVE).

Authors:  Kevin V Carlson; Eric S Rovner; Kavita V Nair; Anna S Deal; Rita M Kristy; Carol R Schermer
Journal:  Adv Ther       Date:  2019-06-20       Impact factor: 3.845

5.  The Prevalence of Overactive Bladder Symptoms in Women in Algeria, Egypt, Jordan and Lebanon: A Cross-Sectional Population-Based Survey.

Authors:  Ghazi Al Edwan; Mohamed S Abdelazim; Salim E Salhab; Yousfi M Jamal; Mohamed A Soliman
Journal:  Adv Ther       Date:  2020-12-22       Impact factor: 3.845

6.  Mapping of incontinence quality of life (I-QOL) scores to assessment of quality of life 8D (AQoL-8D) utilities in patients with idiopathic overactive bladder.

Authors:  Gang Chen; Jonathan T Tan; Kwong Ng; Angelo Iezzi; Jeffrey Richardson
Journal:  Health Qual Life Outcomes       Date:  2014-08-30       Impact factor: 3.186

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.